Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Genetic diversity between human metapneumovirus subgroups.

Stéphane Biacchesi¹, Mario H Skiadopoulos, Guy Boivin

¹Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-8007, USA.

|November 1, 2003

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

National Council on Radiation Protection (NCRP) 2024 annual meeting:<i>advanced and small modular nuclear power reactors</i><sup></sup>.

Journal of radiological protection : official journal of the Society for Radiological Protection·2024

Same author

Vaccine Effectiveness of non-adjuvanted and adjuvanted trivalent inactivated influenza vaccines in the prevention of influenza-related hospitalization in older adults: A pooled analysis from the Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN).

Vaccine·2023

Same author

Infection-induced seroconversion and seroprevalence of SARS-CoV-2 among a cohort of children and youth in Montreal, Canada.

Influenza and other respiratory viruses·2023

Same author

In-vivo and human evidence for potential efficacy of therapeutic polyclonal RSV neutralizing antibodies for palivizumab-resistant RSV infections.

Virology·2023

Same author

Leveraging Influenza Virus Surveillance From 2012 to 2015 to Characterize the Burden of Respiratory Syncytial Virus Disease in Canadian Adults ≥50 Years of Age Hospitalized With Acute Respiratory Illness.

Open forum infectious diseases·2023

Same author

Rapid and Technically Simple Detection of SARS-CoV-2 Variants Using CRISPR Cas12 and Cas13.

The CRISPR journal·2023

Two genetic subgroups of human metapneumovirus (HMPV) show significant sequence diversity, particularly in SH and G proteins. These genetic differences suggest comparable antigenic subgroups to human respiratory syncytial virus (HRSV).

Area of Science:

Virology
Molecular Biology
Immunology

Background:

Human metapneumovirus (HMPV) is a significant respiratory pathogen.
Understanding HMPV genetic diversity is crucial for vaccine and therapeutic development.
Comparison with human respiratory syncytial virus (HRSV) provides a framework for HMPV classification.

Purpose of the Study:

To determine the complete consensus nucleotide sequences of two distinct HMPV isolates (CAN97-83 and CAN98-75).
To compare the genetic and proteomic diversity between these two proposed HMPV genotypes.
To evaluate the potential antigenic relatedness of HMPV subgroups by comparing them to HRSV.

Main Methods:

Complete consensus nucleotide sequencing of HMPV isolates CAN97-83 and CAN98-75.

Related Experiment Videos

Comparative analysis of genome nucleotide sequence identity.

Aggregate proteome amino acid sequence identity analysis.

Main Results:

Genome nucleotide sequence identity between the two HMPV subgroups was 80%, with 90% aggregate proteome amino acid sequence identity.
Greatest diversity was observed in the SH (59% identity) and G (37% identity) proteins.
These diversities were greater than those observed between antigenic subgroups of HRSV.

Conclusions:

The two genetic subgroups of HMPV exhibit significant sequence divergence, particularly in surface proteins.
The observed genetic diversity suggests that these subgroups likely represent distinct antigenic subgroups.
HMPV genetic subgroups are comparable to the antigenic subgroups of HRSV, informing future research and clinical strategies.